Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neoplasm Recurrence, Local × Lomustine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 9 Recurrence 1 Oligodendroglioma 1 Neoplasms 1 Neoplasm Recurrence, Local 1 Medulloblastoma 1 Lymphoma, Large B-Cell, Diffuse 1 Glioma 1 Central Nervous System Neoplasms 1 Burkitt Lymphoma 1 Brain Neoplasms 1

Interventions

tislelizumab 1 pembrolizumab 1 Radiotherapy 1 Paclitaxel 1 Lomustine 1 Cisplatin 1 Cetuximab 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07100730 2026-03-12

IPAX BrIGHT

Telix Pharmaceuticals (Innovations) Pty Limited

Phase 3 Recruiting

Brain Neoplasms, Glioblastoma, Neoplasm Recurrence, Local, Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡